These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 19505813)

  • 21. [Advance in DNA vaccine against Mycobacterium tuberculosis].
    Wang BL; Wang HH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Nov; 27(11):787-90. PubMed ID: 15634398
    [No Abstract]   [Full Text] [Related]  

  • 22. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
    Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
    J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine approaches to prevent tuberculosis.
    Wiker HG; Mustafa T; Målen H; Riise AM
    Scand J Immunol; 2006 Sep; 64(3):243-50. PubMed ID: 16918693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope.
    Shi C; Zhang H; Zhang T; Wang X; Bai B; Zhao Y; Zhang C; Xu Z
    Scand J Immunol; 2009 Nov; 70(5):465-74. PubMed ID: 19874551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM; Bai YL; Shi CH; Gao H; Xue Y; Jiang H; Xu ZK
    APMIS; 2008 Dec; 116(12):1071-81. PubMed ID: 19133010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Inoue Y; Matsumoto M; McMurray DN; Dela Cruz EC; Tan EV; Abalos RM; Burgos JA; Saunderson P; Sakatani M
    Vaccine; 2009 May; 27(25-26):3267-70. PubMed ID: 19200841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The second Geneva Consensus: Recommendations for novel live TB vaccines.
    Walker KB; Brennan MJ; Ho MM; Eskola J; Thiry G; Sadoff J; Dobbelaer R; Grode L; Liu MA; Fruth U; Lambert PH
    Vaccine; 2010 Mar; 28(11):2259-70. PubMed ID: 20074686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculosis subunit vaccine development: impact of physicochemical properties of mycobacterial test antigens.
    Sable SB; Plikaytis BB; Shinnick TM
    Vaccine; 2007 Feb; 25(9):1553-66. PubMed ID: 17166640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New vaccines against tuberculosis.
    Mark Doherty T
    Trop Med Int Health; 2004 Jul; 9(7):818-26. PubMed ID: 15228493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospects for a novel vaccine against tuberculosis.
    Dietrich J; Weldingh K; Andersen P
    Vet Microbiol; 2006 Feb; 112(2-4):163-9. PubMed ID: 16325357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
    Rachman H; Kaufmann SH
    Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis.
    Goldsack L; Kirman JR
    Tuberculosis (Edinb); 2007 Nov; 87(6):465-73. PubMed ID: 17719276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of DNA vaccine during chemotherapy on reactivation and reinfection of Mycobacterium tuberculosis.
    Ha SJ; Jeon BY; Youn JI; Kim SC; Cho SN; Sung YC
    Gene Ther; 2005 Apr; 12(7):634-8. PubMed ID: 15690060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
    Gao H; Li K; Yu S; Xiong S
    Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The search for a tuberculosis vaccine: an elusive quest?
    Nagelkerke NJ; de Vlas SJ; Mahendradhata Y; Ottenhoff TH; Borgdorff M
    Tuberculosis (Edinb); 2006 Jan; 86(1):41-6. PubMed ID: 16253559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.